Key result
Palmitoyl-KVGFFKR triggers platelet activation and aggregation, driving thromboxane synthesis and P-selectin expression.
Answers are grounded in this paper and cite their sources.
Demonstrates that a GpIIb cytoplasmic tail peptide initiates distinct platelet aggregation and thromboxane synthesis pathways, indicating independent intracellular signaling mechanisms.
All integrin alpha subunits contain a highly conserved KXGFFKR motif in their cytoplasmic domains that plays a crucial role in the regulation of integrin affinity for their ligands. We show that a lipid-modified peptide corresponding to the cytoplasmic region, 989-995, of the platelet integrin subunit glycoprotein GpIIb (alphaIIb), palmitoyl-KVGFFKR (Ppep; 10 microM), but not a similarly modified scrambled peptide (palmitoyl-FKFVRGK), can specifically induce platelet activation and aggregation equivalent to that of strong agonists such as thrombin. Ppep-induced aggregation is also associated with indices of platelet activation including thromboxane A2 (TXA2) synthesis (EC50 = 45 +/- 5 microM), secretion of alpha-granules detected as enhanced surface expression of P-selectin (EC50 = 52 +/- 8 microM), and conformational changes in GpIIb/IIIa measured by the monoclonal antibody, PAC-1 (EC50 = 3.7 +/- 1 microM). The TXA2 receptor antagonist, SQ29548, PGE1, and the ADP scavenger, apyrase, differentially inhibit the aggregation response and TXA2 synthesis in response to Ppep. Similarly, GpIIb/IIIa antagonists (RO-449883 and integrelin), which inhibit aggregation by greater than 90%, have little effect on peptide-induced TXA2 synthesis, suggesting that this event is independent of fibrinogen binding to GpIIb/IIIa. Alanine-stepping of the Ppep sequence identifies GFFK(991-994) as the critical residues in all peptide-mediated events. We conclude that this peptide can imitate the cytoplasmic domain of GpIIb and initiate parallel but independent signaling pathways, one leading to ligand binding and platelet aggregation and the other to intracellular signaling events such as TXA2 synthesis and secretion.
No takes yet. Share an insight, caveat, or question.
Stephens et al. (1998) studied Platelet activation and aggregation. Palmitoyl-KVGFFKR peptide (Ppep) vs. Scrambled peptide (palmitoyl-FKFVRGK) was evaluated on Platelet activation and aggregation, including thromboxane A2 synthesis, P-selectin expression, and GpIIb/IIIa conformational changes. Palmitoyl-KVGFFKR (10 microM) induced platelet aggregation, thromboxane A2 synthesis (EC50 45 microM), and P-selectin expression (EC50 52 microM).
Synapse has enriched 10 related papers. Consider them for comparative context: